Weinkle, L.J., Shelton, I., Sillau, S.H., Domen, C., Nair, K.V. & Alvarez, E. (Accepted). Exploring Cannabis use by Patients with Multiple Sclerosis in a state where Cannabis is legal. Poster session presentation at the 70th annual meeting of the American Academy of Neurology, Los Angeles, CA.
Greher, M.R. & Domen, C.H. (2017). Gerstmann, Josef (1887–1969). In J.S. Kreutzer, J. DeLuca, & B. Caplan (Eds.), Encyclopedia of Clinical Neuropsychology. New York, NY: Springer. doi:10.1007/978-3-319-56782-2_617-2
Colorado Department of Public Health & Environment (2017, January). Monitoring Health Concerns Related to Marijuana in Colorado: 2016: Changes in marijuana use patterns, systematic literature review, and possible marijuana-related health effects. Retrieved from: https://www.colorado.gov/cdphe/marijuana-health-report
Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord. 2019 Jan;27:383-390. PubMed PMID: 30502644
Wodushek TR, Domen CH. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery. Appl Neuropsychol Adult. 2018 Sep 5;:1-13. [Epub ahead of print] PubMed PMID: 30183361
Domen CH, Shrestha A, Chapman K, Drees C. The impact of cannabis use on intracarotid amobarbital testing. Epilepsy Behav Rep. 2019;12:100328. PubMed PMID: 31497755
Wodushek TR, Domen CH. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery. Appl Neuropsychol Adult. 2020 Jan-Feb;27(1):9-21. PubMed PMID: 30183361
Domen CH, Collins RL, Davis JJ. The APPCN multisite didactic initiative: Development, benefits, and challenges. Clin Neuropsychol. 2020 Jul 2;:1-18. [Epub ahead of print] PubMed PMID: 32615854
Domen CH, Greher MR, Hosokawa PW, Barnes SL, Hoyt BD, Wodushek TR. Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis?. Arch Clin Neuropsychol. 2020 Jul 24;35(5):511-516. PubMed PMID: 32186676
Wodushek TR, Domen CH. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery. Appl Neuropsychol Adult. 2020 Jan-Feb;27(1):9-21. PubMed PMID: 30183361
Domen CH, Collins RL, Davis JJ. The APPCN multisite didactic initiative: Development, benefits, and challenges. Clin Neuropsychol. 2021 Jan;35(1):115-132. PubMed PMID: 32615854
Holden, S.K., Domen, C.H., Sillau, S., Liu, Y., Leehey, M.A. (2022). Higher risk, higher reward? Self-reported effects of real-world cannabis use in Parkinson’s disease. Movement Disorders Clinical Practice, 9, 340-350. https://doi.org/10.1002/mdc3.13414
Domen, C.H., Sillau, S. Liu, Y., Adkins, M., Rajkovic, S., Bainbridge, J., Sempio, C., Klawitter, J., & Leehey, M.A. (2023). Cognitive safety data from a randomized, double-blind, parallel-group, placebo-controlled phase IIb study of the effects of a cannabidiol and ?9-tetrahydrocannabinol drug on Parkinson disease-related motor symptoms. Movement Disorders, 38, 1341-1346. https://doi.org/10.1002/mds.29447